Filing Flows › Comparisons › RCEL vs IRMD
Avita Medical vs Iradimed: RCEL and IRMD compared
Avita Medical is the larger company: $26.1M of revenue in its latest quarter (Q3 2026) against $24.2M for Iradimed (Q3 2026). Avita Medical is growing faster (+53% against +14% a year earlier). Iradimed is more profitable, with an operating margin of 33.6% against -10.1%.
Where the money goes: RCEL and IRMD
Avita Medical (RCEL) · Q3 2026
Avita Medical, Q3 2026: revenue $26.1M (+53% year over year), operating margin -10.1%, net loss $6.2M, operating cash flow −$710K. The chart follows the revenue to costs, profit and cash.
Iradimed (IRMD) · Q3 2026
Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
| Avita Medical (RCEL) | Iradimed (IRMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $26.1M | $24.2M |
| Revenue growth, Y/Y | +53% | +14% |
| Gross margin | — | 76.3% |
| Operating margin | -10.1% | 33.6% |
| Net earnings | −$6.2M | $6.5M |
| Net margin | -23.8% | 26.9% |
| Operating cash flow | −$710K | $7.0M |
| Free cash flow | — | $6.8M |
| Market value | — | $1.1B |
| P/E | — | 46.8× |
| Analysts’ mean target | — | $118.00 |
Where the revenue comes from
Iradimed
- Total devices revenue: $17.2M (71%)
- Disposables: $5.0M (21%)
- Services and other: $1.2M (5%)
- Amortized Revenue: $801K (3%)
Questions
Which is bigger, Avita Medical or Iradimed?
Avita Medical is the larger company: $26.1M of revenue in its latest quarter (Q3 2026) against $24.2M for Iradimed (Q3 2026).
Is Avita Medical or Iradimed growing faster?
Avita Medical is growing faster (+53% against +14% a year earlier).
Which is more profitable, Avita Medical or Iradimed?
Iradimed is more profitable, with an operating margin of 33.6% against -10.1%.
More: Avita Medical earnings · how Avita Medical makes money · Iradimed earnings · how Iradimed makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Oct 30, 2026). Fiscal quarters can end on different dates. Not investment advice.